Piper Sandler raises target for Cigna Group stock to USD 370

Published on 10/07/2026 at 15:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The target moved from USD 346.00 to USD 370.00 on October 2, 2026. Cigna Group stock costs EUR 244.65 on October 7, 2026 after EUR 243.70, plus 0.39 percent.

Redaktionelles Foto des NYSE-Handelssaals mit Händlern und Bildschirmen voller Gesundheitssektor-Charts — Cigna Group NYSE-Börsensaal Editorial mit Händlern und Gesundheitssektor-Charts, ISIN US1255231003, auf großen S&P-500-Bildschirmen, Illustration mit AI erstellt.

Piper Sandler analyst Jessica Tassan raised the price target for Cigna Group from USD 346.00 to USD 370.00 and kept an Overweight rating on October 2, 2026, as Markets Insider reported. The move puts the analyst view above Cigna's latest operating update, but the near-term debate remains tied to pharmacy benefit margins and execution.

Piper Sandler lifts the target

The USD 370.00 target followed Cigna's September 30, 2026 Investor Day, where the company retained a long-term adjusted earnings-per-share growth range of 10.00 percent to 14.00 percent through 2030, according to Markets Insider. The same report said Cigna established a 2030 adjusted earnings-per-share floor of USD 45.00, giving the target change a longer-term earnings framework.

Second-quarter revenue reaches USD 71.67 billion

Cigna reported USD 71.67 billion of revenue and USD 1.66 billion of net income for the quarter ended June 30, 2026, according to Markets Insider. Revenue rose 6.60 percent from USD 67.23 billion in the year-earlier comparison, while net income increased 8.50 percent from USD 1.53 billion.

The results matter because the target revision is not based only on a valuation reset. Cigna is showing higher quarterly revenue and net income while analysts assess the transition toward a fee-based pharmacy benefit model, a change that can weigh on margins before scale benefits emerge.

Consensus remains above the market quote

MarketBeat counted 23 analyst ratings on October 7, 2026, including 15 Buy ratings and 8 Hold ratings. Its average twelve-month target was USD 338.24, or 23.21 percent above the USD 274.53 reference price used on that page.

That consensus is lower than Piper Sandler's USD 370.00 target but still points to a valuation discussion centered on earnings delivery rather than revenue alone. Cigna's second-quarter figures provide the latest reported comparison for that debate.

Cigna stock holds near EUR 245

Cigna Group stock was trading at EUR 244.65 at Lang & Schwarz on October 7, 2026 at 3:11 p.m. CEST, plus 0.39 percent versus the prior close of EUR 243.70 on October 6, 2026. The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.